Document Detail


Ototopical antifungals and otomycosis: a review.
MedLine Citation:
PMID:  18279975     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
There has been an increase in the prevalence of otomycosis in recent years. This has been linked to the extensive use of antibiotic eardrops. Treatment of otomycosis is challenging, and requires a close follow-up. We present a review of the literature on otomycosis, the topical antifungals most commonly used, and discuss their ototoxic potential. Candida albicans and Aspergillus are the most commonly identified organisms. Antifungals from the Azole class seem to be the most effective, followed by Nystatin and Tolnaftate.
Authors:
Raymundo Munguia; Sam J Daniel
Related Documents :
3335685 - Linear atrophy following intralesional steroid injections.
20186675 - Cannabis-associated arteritis.
21545775 - Angiolipoma in sellar, suprasellar and parasellar region: report on two new cases and r...
8312465 - P(hema) composite as allografting material during therapy of periodontal disease: three...
4083795 - Congenital median clefts of the upper lip.
21104185 - Pediatric cervical spine injuries: a comprehensive review.
Publication Detail:
Type:  Journal Article; Review     Date:  2008-02-14
Journal Detail:
Title:  International journal of pediatric otorhinolaryngology     Volume:  72     ISSN:  0165-5876     ISO Abbreviation:  Int. J. Pediatr. Otorhinolaryngol.     Publication Date:  2008 Apr 
Date Detail:
Created Date:  2008-03-10     Completed Date:  2008-07-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8003603     Medline TA:  Int J Pediatr Otorhinolaryngol     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  453-9     Citation Subset:  IM    
Affiliation:
McGill Auditory Sciences Laboratory, McGill University, Montreal, Qc., Canada H3H1P3.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Topical
Antifungal Agents / administration & dosage,  adverse effects,  therapeutic use*
Aspergillosis / complications
Candidiasis / complications
Ear Diseases / drug therapy*,  microbiology*
Hearing Disorders / chemically induced
Humans
Mycoses / drug therapy*,  microbiology*
Chemical
Reg. No./Substance:
0/Antifungal Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  IFN-beta-regulated genes show abnormal expression in therapy-naïve relapsing-remitting MS mononucle...
Next Document:  Reliability of sample collection and laboratory testing for HPV detection in men.